Article
Practical issues in CAR T-cell therapy
27 Feb 2023
Abstract excerpt
Chimeric antigen receptor (CAR) T-cell therapy presents a revolutionary advancement in personalized cancer treatment. During the production process, the patient's own T-cells are genetically engineered to express a synthetic receptor that binds to a tumor antigen. CAR T-cells are then expanded for clinical use and infused back into the patient's body to attack cancer cells. Although CAR T-cell therapy is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
